Biological Products, Except Diagnostic Substances (Biotech) - Insider Trading Data

Insiders are officers, directors, or significant investors. This page shows insider sentiment and transactions for the Biological industry. Research shows that insider trades are predictive of future stock returns. By examining insider trades for an industry, we can understand what well-informed people think of the overall future industry prospects.

Biological Products, Except Diagnostic Substances (Biotech) - Insider Buy/Sell Ratio

Insider selling and buying is a useful indicator for analyzing the market because it serves as a proxy for their optimism or pessimism in their own companies. By looking at ratio of total selling and buying across the entire market, we might be able to draw some conclusions about the future market.

We offer two charts here. The first one shows the total dollar volume of buying and selling by insiders. The second chart shows the ratio of the number of insiders selling, vs. the number of insiders buying. In both charts, we filter out trades made by indirect holders (such as trusts), and 10% owners (who, although considered an 'insider' by the SEC, do not actually manage the companies in which they are considered insiders).

Corporate Insider Buy Sell Ratio (Dollar Volume) - Biological Products, Except Diagnostic Substances (Biotech)
Corporate Insider Buy Sell Ratio (Insider Count) - Biological Products, Except Diagnostic Substances (Biotech)
Biological Products, Except Diagnostic Substances (Biotech) - Transaction History

Click the link icon to see the full transaction history. Transactions reported as part of a 10b5-1 automatic trading plan will have an X in the column marked 10b-5.

Tran
Date
Security Form Insider Code 10b5-1 Direct Share
Price
Shares
Changed
2025-09-02 PCVX / Vaxcyte, Inc. 4 Cowan Elvia F - Taxes D 31.56 -242
2025-09-02 IOVA / Iovance Biotherapeutics, Inc. 4 GRAF FINCKENSTEIN FRIEDRICH F - Taxes D 2.19 -6,448
2025-09-02 IOVA / Iovance Biotherapeutics, Inc. 4 Puri Raj K. F - Taxes D 2.19 -2,467
2025-09-02 IOVA / Iovance Biotherapeutics, Inc. 4 BILINSKY IGOR F - Taxes D 2.19 -6,250
2025-09-02 PCVX / Vaxcyte, Inc. 4 Wassil Jim F - Taxes D 31.56 -1,587
2025-09-02 PCVX / Vaxcyte, Inc. 4 GUGGENHIME ANDREW F - Taxes D 31.56 -1,429
2025-09-02 PCVX / Vaxcyte, Inc. 4 PICKERING GRANT F - Taxes D 31.56 -4,563
2025-09-02 PCVX / Vaxcyte, Inc. 4 Dhaliwal Harpreet S. F - Taxes D 31.56 -464
2025-09-02 PCVX / Vaxcyte, Inc. 4 Dhaliwal Harpreet S. F - Taxes D 31.56 -783
2025-09-02 PCVX / Vaxcyte, Inc. 4 GUGGENHIME ANDREW F - Taxes D 31.56 -2,381
2025-09-02 PCVX / Vaxcyte, Inc. 4 Wassil Jim F - Taxes D 31.56 -1,429
2025-09-02 PCVX / Vaxcyte, Inc. 4 Wassil Jim F - Taxes D 31.56 -1,270
2025-09-02 PCVX / Vaxcyte, Inc. 4 GUGGENHIME ANDREW F - Taxes D 31.56 -1,270
2025-09-02 PCVX / Vaxcyte, Inc. 4 Dhaliwal Harpreet S. F - Taxes D 31.56 -291
2025-09-02 PCVX / Vaxcyte, Inc. 4 PICKERING GRANT F - Taxes D 31.56 -3,420
2025-09-02 INKT / MiNK Therapeutics, Inc. 4 Corvese Brian A - Award D 13.86 1,290
2025-09-02 INKT / MiNK Therapeutics, Inc. 4 Ryan Barbara A - Award D 13.86 1,281
2025-09-02 INKT / MiNK Therapeutics, Inc. 4 Kadlec Robert Peter A - Award D 13.86 975
2025-09-02 INKT / MiNK Therapeutics, Inc. 4 Behner Peter A - Award D 13.86 1,173
2025-09-02 RGEN / Repligen Corporation 4 Hughes Violetta A - Award D 4,142
2025-09-02 INKT / MiNK Therapeutics, Inc. 4 WIINBERG ULF A - Award D 13.86 1,011
2025-09-01 RGNX / REGENXBIO Inc. 4 Malzahn Craig F - Taxes D 8.93 -234
2025-09-01 RGNX / REGENXBIO Inc. 4 Chan Mitchell F - Taxes D 8.93 -4,901
2025-08-31 BCAB / BioAtla, Inc. 4 SHORT JAY M PHD F - Taxes D 0.4555 -6,347
2025-08-31 BCAB / BioAtla, Inc. 4 Vasquez Christian F - Taxes D 0.4555 -1,566
2025-08-31 BCAB / BioAtla, Inc. 4 WALDRON RICHARD A F - Taxes D 0.4555 -2,371
2025-08-31 BCAB / BioAtla, Inc. 4 Sievers Eric F - Taxes D 0.4555 -2,729
2025-08-31 FENC / Fennec Pharmaceuticals Inc. 4 Andrade Robert A - Award D 2,431
2025-08-31 FENC / Fennec Pharmaceuticals Inc. 4 Raykov Rosty A - Award D 5,208
2025-08-29 MRNA / Moderna, Inc. 4 Hoge Stephen M - Exercise D 651
2025-08-29 MRNA / Moderna, Inc. 4 Klinger Shannon Thyme M - Exercise D 232
2025-08-29 BIIB / Biogen Inc. 4 Singhal Priya M - Exercise D 1,669
2025-08-29 BIIB / Biogen Inc. 4 Singhal Priya F - Taxes D 132.22 -807
2025-08-29 MRNA / Moderna, Inc. 4 Hoge Stephen F - Taxes D 24.47 -315
2025-08-29 MRNA / Moderna, Inc. 4 Klinger Shannon Thyme F - Taxes D 24.47 -113
2025-08-29 BCRX / BioCryst Pharmaceuticals, Inc. 4 MILANO VINCENT A - Award D 8.31 676
2025-08-29 BCRX / BioCryst Pharmaceuticals, Inc. 4 Frank Steven A - Award D 8.31 1,353
2025-08-29 BCRX / BioCryst Pharmaceuticals, Inc. 4 McKee Amy E A - Award D 8.31 676
2025-08-29 LXEO / Lexeo Therapeutics, Inc. 4 Tamayo Louis Edward A - Award D 45,000
2025-08-28 ADAP / Adaptimmune Therapeutics plc - Depositary Receipt (Common Stock) 4 Bertrand William C JR S - Sale D 0.0101 -207,000
2025-08-28 GILD / Gilead Sciences, Inc. 4 O'Day Daniel Patrick S - Sale D 113.63 -10,000
2025-08-28 VOR / Vor Biopharma Inc. 4 Reprogrammed Interchange LLC S - Sale D 2.0115 -806,351
2025-08-28 MRNA / Moderna, Inc. 4 Hoge Stephen M - Exercise D 611
2025-08-28 MRNA / Moderna, Inc. 4 Klinger Shannon Thyme M - Exercise D 329
2025-08-28 MRNA / Moderna, Inc. 4 Mock James M M - Exercise D 329
2025-08-28 MRNA / Moderna, Inc. 4 Klinger Shannon Thyme F - Taxes D 25.10 -160
2025-08-28 MRNA / Moderna, Inc. 4 Mock James M F - Taxes D 25.10 -160
2025-08-28 MRNA / Moderna, Inc. 4 Hoge Stephen F - Taxes D 25.10 -296
2025-08-28 ACLX / Arcellx, Inc. 4 Elghandour Rami F - Taxes D 70.25 -546,938
2025-08-27 VOR / Vor Biopharma Inc. 4 Reprogrammed Interchange LLC S - Sale D 2.0053 -611,647
P
Köp på öppna marknaden eller privat köp av icke-derivatsäkerhet
S
Köp på öppna marknaden eller privat försäljning av icke-derivatsäkerhet
A
Bevilja, tilldelning eller annat förvärv av värdepapper från företaget (såsom en option)
C
Omvandling av derivat
D
Försäljning eller överföring av värdepapper tillbaka til företaget
F
Betalning av lösenpris eller skatteskuld med del av värdepapper som erhållits från bolaget
G
Överlåtelse av värdepapper från eller till insidern
K
Aktieswappar och liknande säkringsaffärer
M
Utövande eller omvandling av derivatsäkerhet som erhållits från företaget (som en option)
V
En transaktion friviligt rapporterad på schema 4
J
Andra (med en fotnot som beskriver transaktionen)